JP2013507954A5 - - Google Patents

Download PDF

Info

Publication number
JP2013507954A5
JP2013507954A5 JP2012535105A JP2012535105A JP2013507954A5 JP 2013507954 A5 JP2013507954 A5 JP 2013507954A5 JP 2012535105 A JP2012535105 A JP 2012535105A JP 2012535105 A JP2012535105 A JP 2012535105A JP 2013507954 A5 JP2013507954 A5 JP 2013507954A5
Authority
JP
Japan
Prior art keywords
cancer cells
pharmaceutical composition
peptides
seq
nos
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2012535105A
Other languages
English (en)
Japanese (ja)
Other versions
JP5751519B2 (ja
JP2013507954A (ja
Filing date
Publication date
Priority claimed from KR1020090101003A external-priority patent/KR101061017B1/ko
Application filed filed Critical
Publication of JP2013507954A publication Critical patent/JP2013507954A/ja
Publication of JP2013507954A5 publication Critical patent/JP2013507954A5/ja
Application granted granted Critical
Publication of JP5751519B2 publication Critical patent/JP5751519B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2012535105A 2009-10-23 2010-08-24 白血球の血管外遊出またはガン細胞の成長及び／もしくは転移を抑制するポリペプチドまたはその融合蛋白質 Expired - Fee Related JP5751519B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
KR1020090101003A KR101061017B1 (ko) 2009-10-23 2009-10-23 암세포의 성장 및/또는 전이 억제용 약학 조성물
KR10-2009-0101003 2009-10-23
PCT/KR2010/005619 WO2011049289A2 (ko) 2009-10-23 2010-08-24 백혈구의 혈관외유출 또는 암세포의 성장 및/또는 전이를 억제하는 폴리펩타이드 또는 그의 융합 단백질

Publications (3)

Publication Number Publication Date
JP2013507954A JP2013507954A (ja) 2013-03-07
JP2013507954A5 true JP2013507954A5 (https=) 2014-08-07
JP5751519B2 JP5751519B2 (ja) 2015-07-22

Family

ID=43900764

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2012535105A Expired - Fee Related JP5751519B2 (ja) 2009-10-23 2010-08-24 白血球の血管外遊出またはガン細胞の成長及び／もしくは転移を抑制するポリペプチドまたはその融合蛋白質

Country Status (6)

Country Link
US (1) US8530421B2 (https=)
EP (2) EP2491944A4 (https=)
JP (1) JP5751519B2 (https=)
KR (1) KR101061017B1 (https=)
CN (1) CN102711792A (https=)
WO (1) WO2011049289A2 (https=)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0689637B2 (ja) 1990-08-28 1994-11-09 株式会社荏原製作所 トンネル微気圧波低減装置
KR101644982B1 (ko) * 2015-07-23 2016-08-02 주식회사 엔솔바이오사이언스 신규 펩타이드 및 그 용도
ES2965061T3 (es) * 2016-03-02 2024-04-10 Univ Pittsburgh Commonwealth Sys Higher Education Nanovesículas unidas a matriz y su uso
US20200095296A1 (en) * 2017-06-05 2020-03-26 The Trustees Of Columbia University In The City Of New York Use of peptides as biomarkers in the diagnosis, confirmation and treatment of a neurological disorder and tcr and/or hla immunoprofiling in neurodegenerative disease
KR102268921B1 (ko) * 2019-12-10 2021-06-23 강원대학교산학협력단 p53을 활성화하는 펩타이드를 포함하는 조성물
EP4046647A4 (en) * 2019-12-11 2023-08-30 Supadelixir Inc. PHARMACEUTICAL COMPOSITION COMPRISING A PEPTIDE WHICH INHIBITS THE INTERACTION OF P53 AND FOXO4
KR20230033097A (ko) * 2021-08-27 2023-03-08 (주)티카로스 기능이 강화된 신규 키메라 항원 수용체(car)

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5541087A (en) * 1994-09-14 1996-07-30 Fuji Immunopharmaceuticals Corporation Expression and export technology of proteins as immunofusins
EP1019438B1 (en) * 1997-09-30 2009-01-21 Peviva AB Apoptosis-related compounds and their use
EP1133317A1 (de) * 1998-11-26 2001-09-19 Pentapharm AG Transportsystemkonjugate
US6451969B1 (en) * 1999-01-15 2002-09-17 The Burnham Institute Methods for inhibiting tumor metastasis, and peptides useful therfor
AU3395900A (en) * 1999-03-12 2000-10-04 Human Genome Sciences, Inc. Human lung cancer associated gene sequences and polypeptides
GB9911683D0 (en) * 1999-05-19 1999-07-21 Chiron Spa Antigenic peptides
ATE511856T1 (de) * 2000-03-13 2011-06-15 Cornell Res Foundation Inc Blockieren der leukozytenemigration und entzündung durch störung mit cd99/hec2
CH694935A5 (de) * 2000-07-26 2005-09-30 Straumann Holding Ag Oberflaechenmodifizierte Implantate.
US7460960B2 (en) * 2002-05-10 2008-12-02 Epitome Biosystems, Inc. Proteome epitope tags and methods of use thereof in protein modification analysis
US20050240009A1 (en) * 2002-08-21 2005-10-27 Carr Francis J T-cell epitopes in staphylococcal enterotoxin b
US7385027B2 (en) * 2003-01-07 2008-06-10 University Of Kentucky Research Foundation Membrane-permeable peptide capable of calpain inhibition
WO2005074986A2 (en) * 2004-02-10 2005-08-18 Genobiotix Aps Bioactive species capable of interfering with a microbial toxin-antitoxin complex and methods for evaluation and use of said bioactive species
WO2007005898A2 (en) 2005-07-05 2007-01-11 Cornell Research Foundation, Inc. Blocking leukocyte emigration and inflammation by interfering with cd99l2
KR100793949B1 (ko) * 2006-07-19 2008-01-16 강원대학교산학협력단 염증 질환의 예방 또는 치료 활성을 갖는 폴리펩타이드또는 그의 융합 단백질
KR100793947B1 (ko) * 2006-06-30 2008-01-16 강원대학교산학협력단 암세포의 성장 및 전이 억제 활성을 갖는 폴리펩타이드또는 그의 융합 단백질
WO2007037601A1 (en) 2005-09-28 2007-04-05 Knu-Industry Cooperation Foundation Polypeptide inhibiting transmigration of leukocytes or growth and/or metastasis of cancer cells, and fusion protein thereof
KR100941678B1 (ko) * 2007-12-17 2010-02-12 강원대학교산학협력단 암세포의 전이 억제 활성을 갖는 폴리펩타이드 또는 그의융합 단백질
KR101074005B1 (ko) * 2009-02-26 2011-10-17 재단법인춘천바이오산업진흥원 백혈구의 혈관외유출 억제 활성을 갖는 폴리펩타이드 또는 그의 융합 단백질

Similar Documents

Publication Publication Date Title
JP2013507954A5 (https=)
EA201400172A1 (ru) Устойчивая к разрушению таблетка, которая обеспечивает немедленное высвобождение лекарственного средства
CL2013003331A1 (es) Tableta de liberacion inmediata a prueba de alteracion que comprende (i) una matriz, y (ii) una pluralidad de material particulado, que comprende un opiaceo y un polimero de oxido de polietileno de mas de 20.000 g/mol, donde el multiparticulado forma una fase discontinua dentro de la matriz.
JP2009286795A5 (https=)
WO2013066839A3 (en) Compounds and methods
NZ602557A (en) Solid form of n-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide
PH12013500152A1 (en) New aminopyrazoloquinazolines
MX345928B (es) Composiciones terapeuticamente activas y metodos de uso de las mismas.
WO2011084991A3 (en) Fluorinated hdac inhibitors and uses thereof
MX387667B (es) Composiciones corticosteroides.
MX385898B (es) Moleculas de fusion derivadas de la toxina colix para suministro oral de una carga biologicamente activa.
NI201100155A (es) Composiciones y métodos para el tratamiento prolongado con aminopiridinas
TN2012000046A1 (en) Pharmaceutical compositions for the treatment of cancer and other diseases or disorfers
JP2018048151A5 (https=)
UA100127C2 (ru) Пептид cdh3 и лекарственное средство, содержащее его
NZ602845A (en) Inhibiting peptides derived from trem-like transcript 1 (tlt-1) and uses thereof
JP2015533791A5 (https=)
NZ596313A (en) Pharmaceutical compositions containing antifungal peptides
PH12012502323A1 (en) Levoisovalerylspiramycin i, ii or iii, preparations, preparation methods and uses thereof
MX2020010807A (es) Peptidos promotores del crecimiento y usos de los mismos.
JP2016510596A5 (https=)
JP2013542196A5 (https=)
MX348555B (es) Agente preventivo o terapeutico contra la fibrosis.
MY159756A (en) Nitrile derivatives and their pharmaceutical use and compositions
JP2015506352A5 (https=)